戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ardiography, pulmonary function tests, and a cardiopulmonary exercise test.
2  undergone a Fontan procedure and subsequent cardiopulmonary exercise test.
3 ther medical risk factors, completed maximal cardiopulmonary exercise tests.
4 dimensional and Doppler echocardiography and cardiopulmonary exercise tests.
5 s with HF who underwent clinically indicated cardiopulmonary exercise testing.
6 ssist device implantation) for 2 years after cardiopulmonary exercise testing.
7 chocardiograms with partial LVAD support and cardiopulmonary exercise testing.
8         The VE/VCO2 slope was determined via cardiopulmonary exercise testing.
9 0.03) were associated with maximal output on cardiopulmonary exercise testing.
10 LBBB) were studied with echocardiography and cardiopulmonary exercise testing.
11 New York Heart Association (NYHA) class, and cardiopulmonary exercise testing.
12             P = 0.005) but no relations with cardiopulmonary exercise testing.
13 logy of Fallot (n=10) underwent MR-augmented cardiopulmonary exercise testing.
14 ) with hypertrophic cardiomyopathy underwent cardiopulmonary exercise testing.
15 ments, including stress echocardiography and cardiopulmonary exercise testing.
16 %) underwent maximum upright cycle ergometry cardiopulmonary exercise testing.
17 ntrol subjects were studied with incremental cardiopulmonary exercise testing.
18 cular measurements, 6-min walking tests, and cardiopulmonary exercise testing.
19 aired systolic function who are referred for cardiopulmonary exercise testing.
20 ratively and at 3 months postoperatively and cardiopulmonary exercise testing 3 months postoperativel
21 ise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 c
22 ents with heart failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT)
23                     All patients underwent a cardiopulmonary exercise test and a phosphorus magnetic
24                 Between 2001 and 2009, using cardiopulmonary exercise test and echocardiography, we s
25 rves; secondary functional outcomes included cardiopulmonary exercise testing and arterial compliance
26                       All subjects underwent cardiopulmonary exercise testing and cardiac magnetic re
27                           Patients underwent cardiopulmonary exercise testing and echocardiography to
28 ogether with conventional methods, including cardiopulmonary exercise testing and echocardiography.
29 patients with heart failure underwent serial cardiopulmonary exercise testing and evaluation of exert
30 underwent baseline Doppler echocardiography, cardiopulmonary exercise testing, and cardiac MRI.
31 rwent electrocardiography, echocardiography, cardiopulmonary exercise testing, and cardiovascular mag
32 kers from clinical data, ECG, laboratory and cardiopulmonary exercise testing, and echocardiography.
33                            Echocardiography, cardiopulmonary exercise testing, and laboratory evaluat
34 unction testing, respiratory muscle testing, cardiopulmonary exercise testing, and muscle biopsy.
35 n fraction </=35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine mana
36 -five consecutive patients with CF completed cardiopulmonary exercise testing as part of their pretra
37 er kilogram of body weight per minute during cardiopulmonary exercise testing at 6 months.
38 heart disease (age, 33+/-13 years) underwent cardiopulmonary exercise testing at a single center over
39 e was peak oxygen consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 2
40 f age during incremental cycle and treadmill cardiopulmonary exercise tests at three test sites, corr
41                           Patients underwent cardiopulmonary exercise testing before and after treatm
42 thout PH who performed a submaximal invasive cardiopulmonary exercise test between January 2013 and J
43  and maximal exercise capacity (peak VO2) on cardiopulmonary exercise testing, both measured at 12 mo
44                                 Conventional cardiopulmonary exercise testing can objectively measure
45                                        Using cardiopulmonary exercise testing, cardiovascular reserve
46                                              Cardiopulmonary exercise test combined with simultaneous
47                                            A cardiopulmonary exercise test (CPET) with expired gas an
48        Unlike adult patients, the utility of cardiopulmonary exercise testing (CPET) in children as a
49 nes, and meta-analyses concerning the use of cardiopulmonary exercise testing (CPET) in preoperative
50 ation exists regarding the safety of maximal cardiopulmonary exercise testing (CPET) or the mechanism
51    Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thoro
52                                      Because cardiopulmonary exercise testing (CPET) provides informa
53                                              Cardiopulmonary exercise testing (CPET) was prospectivel
54 he exercise limitation in patients with PPH, cardiopulmonary exercise testing (CPET) with gas exchang
55                Interpretation of incremental cardiopulmonary exercise tests (CPET) might be enhanced
56                                              Cardiopulmonary exercise test (CPX) responses are strong
57                 In the past several decades, cardiopulmonary exercise testing (CPX) has seen an expon
58                                              Cardiopulmonary exercise testing (CPX) with measurement
59          Clinical, electrocardiographic, and cardiopulmonary exercise test data from 332 male profess
60                                      Whether cardiopulmonary exercise testing data predict survival h
61              Participants underwent baseline cardiopulmonary exercise testing, echocardiogram, biomar
62 atched for age, height, and weight underwent cardiopulmonary exercise testing, echocardiography inclu
63 ization, including serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and
64                   Subjects were studied with cardiopulmonary exercise testing, echocardiography, and
65 d preserved exercise tolerance, the value of cardiopulmonary exercise testing for risk stratification
66 ak VO2>80% predicted) who underwent invasive cardiopulmonary exercise testing for unexplained exertio
67  data at rest and during maximal incremental cardiopulmonary exercise testing from 87 consecutive hea
68                                              Cardiopulmonary exercise test, functional class, blood s
69 re classified according to peak VO(2) during cardiopulmonary exercise testing (&gt;14, 10-14, and <10 mL
70 chocardiography at rest and immediately post-cardiopulmonary exercise test in 207 patients (63 +/- 8
71 eft shunting can be detected by noninvasive, cardiopulmonary exercise testing in patients with PPH.
72                               The results of cardiopulmonary exercise testing in patients with struct
73     This article reviews the applications of cardiopulmonary exercise testing in prognosis among pati
74  improved exercise, we performed progressive cardiopulmonary exercise testing, including rest and pea
75                                              Cardiopulmonary exercise testing indices peak oxygen con
76 clinical, laboratory, echocardiographic, and cardiopulmonary exercise test investigations at study en
77                  We have demonstrated that a cardiopulmonary exercise test is feasible in ambulatory
78 risk stratification imperative, but although cardiopulmonary exercise test is well established as a p
79                                 MR-augmented cardiopulmonary exercise testing is feasible in both hea
80                                              Cardiopulmonary exercise testing is feasible in children
81                                              Cardiopulmonary exercise testing is often used to evalua
82 or II, 6-min walk distance >/= 380 to 440 m, cardiopulmonary exercise test-measured peak oxygen consu
83                                              Cardiopulmonary exercise testing measures oxygen uptake
84                       Pre- and post-training cardiopulmonary exercise tests, MRI, and echocardiograph
85 consisting of ECG, Holter, echocardiography, cardiopulmonary exercise testing, N-terminal pro-brain n
86                         Retrospectively, the cardiopulmonary exercise tests of 71 PPH patients were s
87                     The relationship between cardiopulmonary exercise testing parameters and pregnanc
88                                              Cardiopulmonary exercise testing parameters are powerful
89   Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used
90 e provide 5-year survival prospects based on cardiopulmonary exercise testing parameters in this grow
91         We hypothesized that combinations of cardiopulmonary exercise testing parameters may provide
92 logy, socioeconomic status, quality of life, cardiopulmonary exercise testing parameters, and biomark
93                         Peak symptom-limited cardiopulmonary exercise tests performed in 57 clinicall
94 riuretic peptide, peak oxygen consumption by cardiopulmonary exercise testing (pkVO2), New York Heart
95 e production), and heart rate reserve during cardiopulmonary exercise testing predicted risk of early
96                                 Preoperative cardiopulmonary exercise testing predicts surgical outco
97                                              Cardiopulmonary exercise testing provides prognostic inf
98                                              Cardiopulmonary exercise testing provides strong prognos
99                    On multivariate analysis, cardiopulmonary exercise tests, pulmonary capillary wedg
100                                              Cardiopulmonary exercise testing rather than symptoms sh
101 rformance on a low-technology exercise test, cardiopulmonary exercise testing should be considered.
102  then had pre-randomisation assessments with cardiopulmonary exercise testing, symptom questionnaires
103                                              Cardiopulmonary exercise test time increased by 0.48 min
104 surgical patients, heart rate recovery after cardiopulmonary exercise testing, time/frequency measure
105                                              Cardiopulmonary exercise testing, tissue Doppler echocar
106  developed magnetic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal an
107                       All subjects underwent cardiopulmonary exercise testing to analyze aerobic para
108 ixty-one HCC patients underwent preoperative cardiopulmonary exercise testing to determine their anae
109 ejection fraction </=40%) patients underwent cardiopulmonary exercise testing to evaluate aerobic per
110                                              Cardiopulmonary exercise testing variables included peak
111                                           On cardiopulmonary exercise testing, ventilatory response t
112            Exercise duration on the baseline cardiopulmonary exercise test was the most important pre
113          Heart rate recovery after a maximal cardiopulmonary exercise test was used as a surrogate fo
114                                 Preoperative cardiopulmonary exercise testing was included.
115                                              Cardiopulmonary exercise testing was performed in 335 co
116                                              Cardiopulmonary exercise testing was performed in 500 pa
117                                              Cardiopulmonary exercise testing was performed on 232 co
118                               Using invasive cardiopulmonary exercise testing, we hypothesized that e
119 1), none of the other endpoints derived from cardiopulmonary exercise testing were met.
120                                      MRI and cardiopulmonary exercise testing were performed before a
121                                Parameters of cardiopulmonary exercise testing were recently identifie
122 is of HFNEF and proven cardiac limitation by cardiopulmonary exercise testing were studied by standar
123 al for patients with systolic heart failure, cardiopulmonary exercise tests were performed at baselin
124        The results of pulmonary-function and cardiopulmonary-exercise testing were generally within n
125           Potential predictors, derived from cardiopulmonary exercise testing, were compared with oth
126  (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates per
127  healthy controls performed a maximal graded cardiopulmonary exercise test with continuous measuremen
128                                              Cardiopulmonary exercise testing with echocardiographic
129 n=18), and control subjects (n=30) underwent cardiopulmonary exercise testing with invasive hemodynam
130             We performed maximum incremental cardiopulmonary exercise testing with invasive hemodynam
131                                 We performed cardiopulmonary exercise testing with invasive monitorin
132  shunt and patients with large PFO underwent cardiopulmonary exercise tests with contrast transcrania
133 otal of 406 consecutive clinically indicated cardiopulmonary exercise tests with radial and pulmonary
134 bjects performed supine-cycle maximal-effort cardiopulmonary exercise tests, with measurements of car
135 h congenital heart disease who had undergone cardiopulmonary exercise testing within 2 years of pregn
136                               Survival after cardiopulmonary exercise testing without HTx or ventricu
137 l volume % predicted (p=0.04), lower maximal cardiopulmonary exercise testing workload (p=0.002), gre

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
Page Top
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト